Rodgers Brothers’s AstraZeneca AZN Stock Holding History

Rodgers Brothers’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$282K	Hold	1,430	–	–	0.03%	215
2025 Q4	$263K	Hold	1,430	–	–	0.03%	215
2025 Q3	$219K	Buy	+1,430	New	+$216K	0.03%	229
2025 Q2	–	Sell	-1,430	Closed	-$210K	–	240
2025 Q1	$210K	Buy	+1,430	New	+$207K	0.03%	226
2024 Q4	–	Sell	-1,430	Closed	-$223K	–	231
2024 Q3	$223K	Hold	1,430	–	–	0.03%	225
2024 Q2	$223K	Buy	+1,430	New	+$215K	0.03%	225
2014 Q2	–	Sell	-3,119	Closed	-$202K	–	149
2014 Q1	$202K	Buy	+3,119	New	+$201K	0.1%	161

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Rodgers Brothers's AZN Position: Q1 2026 in Review

Rodgers Brothers held its AstraZeneca (AZN) position steady in Q1 2026 at 1,430 shares worth $282K. The position accounts for 0.03% of the portfolio, ranked #215.

Rodgers Brothers first reported a position in AZN in Q1 2014 and has held it in 7 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Rodgers Brothers held 1,430 shares of AstraZeneca worth $282K as of Q1 2026.
Rodgers Brothers left its AstraZeneca share count unchanged in Q1 2026.
AstraZeneca made up 0.03% of Rodgers Brothers's portfolio in Q1 2026, its #215 holding.
Rodgers Brothers first reported a position in AstraZeneca in Q1 2014 and has held it in 7 quarters since.
1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Rodgers Brothers's 13F filing for Q1 2026, filed 14 May 2026.